News
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...
Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...
We recently published a list of Jim Cramer Recently Discussed These 15 Stocks. In this article, we are going to take a look ...
Despite Pfizer management's cost-cutting and a large drug pipeline, revenue growth remains uncertain. Click here to read an ...
Pfizer Inc. closed 26.70% short of its 52-week high of $31.54, which the company achieved on July 30th.
StockStory.org on MSN4d
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer ...
5d
24/7 Wall St. on MSN2 High-Yield Dividend Stocks Yielding Over 6% That’ll Pay You to WaitHigh-yielding dividend stocks may not be the ticket to superior returns, but they can rank pretty high on the list of nice-to ...
Although Pfizer has made some efforts to turn things around, they have been insufficient. Pfizer's poor performance since ...
German-based BioNTech , best known for its collaboration with Pfizer during the COVID-19 pandemic for developing vaccines, ...
10d
Zacks Investment Research on MSNPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results